China Sunsine Chemical Holdings Ltd. (SGX:QES)
Singapore · Delayed Price · Currency is SGD 0.6600
-0.0050 (-0.75%)
Aug 28, 2026, 5:04 PM SGT
SGX:QES Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,595 | 3,277 | 3,516 | 3,490 | 3,825 | 3,725 | |
Revenue Growth | 4.00% | -6.77% | 0.72% | -8.75% | 2.68% | 59.63% |
Cost of Revenue | 2,734 | 2,507 | 2,665 | 2,692 | 2,661 | 2,679 |
Gross Profit | 860.5 | 770.3 | 850.03 | 798.92 | 1,164 | 1,046 |
Selling, General & Admin | 371.17 | 345.07 | 321.47 | 303.91 | 375.3 | 327.38 |
Research & Development | 12.72 | 5.22 | 86.19 | 119.36 | 142.41 | 110.81 |
Operating Expenses | 382.64 | 349.04 | 405.57 | 423.85 | 514.13 | 438.24 |
Operating Income | 477.86 | 421.26 | 444.46 | 375.07 | 649.8 | 608.22 |
Interest & Investment Income | 67.24 | 67.44 | 55.63 | 36.02 | 16.15 | 24.24 |
Currency Exchange Gain (Loss) | -72.68 | -20.88 | 28.1 | 17.43 | 27.69 | -6.11 |
Other Non Operating Income (Expenses) | 46.87 | 38.67 | 54.78 | 30.82 | 40.13 | 72.77 |
EBT Excluding Unusual Items | 519.29 | 506.49 | 582.98 | 459.34 | 733.77 | 699.12 |
Gain (Loss) on Sale of Assets | - | - | 4.99 | - | - | - |
Asset Writedown | -2.92 | -2.92 | -2.91 | -6.11 | - | - |
Pretax Income | 516.37 | 503.57 | 585.06 | 453.23 | 733.77 | 699.12 |
Income Tax Expense | 99.84 | 98.64 | 161.2 | 80.76 | 91.33 | 192.79 |
Net Income | 416.53 | 404.93 | 423.86 | 372.47 | 642.44 | 506.33 |
Net Income to Common | 416.53 | 404.93 | 423.86 | 372.47 | 642.44 | 506.33 |
Net Income Growth | -12.82% | -4.47% | 13.80% | -42.02% | 26.88% | 131.43% |
Shares Outstanding (Basic) | 953 | 953 | 956 | 963 | 969 | 971 |
Shares Outstanding (Diluted) | 953 | 953 | 956 | 963 | 969 | 971 |
Shares Change | -0.03% | -0.27% | -0.75% | -0.62% | -0.14% | -0.21% |
EPS (Basic) | 0.44 | 0.42 | 0.44 | 0.39 | 0.66 | 0.52 |
EPS (Diluted) | 0.44 | 0.42 | 0.44 | 0.39 | 0.66 | 0.52 |
EPS Growth | -12.79% | -4.21% | 14.66% | -41.66% | 27.06% | 131.91% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 122.6 | 376.4 | 463.16 | 422.22 | 121.03 | 158.11 |
Free Cash Flow Per Share | 0.13 | 0.40 | 0.48 | 0.44 | 0.13 | 0.16 |
Dividend Per Share | 0.109 | 0.109 | 0.107 | 0.081 | 0.051 | 0.047 |
Dividend Growth | 1.68% | 1.68% | 32.74% | 56.66% | 9.17% | -4.60% |
Gross Margin | 23.94% | 23.50% | 24.18% | 22.89% | 30.43% | 28.09% |
Operating Margin | 13.29% | 12.85% | 12.64% | 10.75% | 16.99% | 16.33% |
Profit Margin | 11.59% | 12.35% | 12.06% | 10.67% | 16.80% | 13.59% |
Free Cash Flow Margin | 3.41% | 11.48% | 13.18% | 12.10% | 3.16% | 4.24% |
EBITDA | 630.62 | 567.22 | 577.41 | 525.81 | 813.11 | 738.45 |
EBITDA Margin | 17.54% | 17.31% | 16.42% | 15.06% | 21.26% | 19.82% |
D&A For EBITDA | 152.77 | 145.97 | 132.95 | 150.74 | 163.31 | 130.23 |
EBIT | 477.86 | 421.26 | 444.46 | 375.07 | 649.8 | 608.22 |
EBIT Margin | 13.29% | 12.85% | 12.64% | 10.75% | 16.99% | 16.33% |
Effective Tax Rate | 19.34% | 19.59% | 27.55% | 17.82% | 12.45% | 27.58% |